0001209191-18-063552.txt : 20181219 0001209191-18-063552.hdr.sgml : 20181219 20181219175911 ACCESSION NUMBER: 0001209191-18-063552 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181217 FILED AS OF DATE: 20181219 DATE AS OF CHANGE: 20181219 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Popovits Kimberly J CENTRAL INDEX KEY: 0001333482 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-51541 FILM NUMBER: 181244284 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: GENOMIC HEALTH INC CENTRAL INDEX KEY: 0001131324 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 770552594 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-556-9300 MAIL ADDRESS: STREET 1: 301 PENOBSCOT DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-12-17 0 0001131324 GENOMIC HEALTH INC GHDX 0001333482 Popovits Kimberly J 301 PENOBSCOT DR. REDWOOD CITY CA 94063 1 1 0 0 President and CEO Common Stock 2018-11-27 5 G 0 E 589 0.00 D 57068 D Common Stock 2018-12-17 4 S 0 7707 65.8472 D 159275 I Held by the Popovits 2010 Trust Common Stock 2018-12-17 4 S 0 9079 66.7849 D 150196 I Held by the Popovits 2010 Trust Common Stock 2018-12-17 4 S 0 7014 67.8905 D 143182 I Held by the Popovits 2010 Trust Common Stock 2018-12-17 4 S 0 1200 68.5276 D 141982 I Held by the Popovits 2010 Trust Common Stock 2018-12-18 4 S 0 4070 65.7865 D 137912 I Held by the Popovits 2010 Trust Common Stock 2018-12-18 4 S 0 17208 66.7383 D 120704 I Held by the Popovits 2010 Trust Common Stock 2018-12-18 4 S 0 3722 67.4642 D 116982 I Held by the Popovits 2010 Trust Common Stock 12298 I Held by Morgan Stanley as Custodian for Benefit of Kimberly Popovits Includes an aggregate of 51,204 shares of common stock issuable pursuant to previously reported restricted stock units that have not vested. These sales of common stock were effected pursuant to Rule 10b5-1 sales plan adopted by the reporting person on August 14, 2018. Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $65.32 to $66.30. Represents weighted average sale price. Actual sale prices ranged from $66.34 to $67.315. Represents weighted average sale price. Actual sale prices ranged from $67.36 to $68.34. Represents weighted average sale price. Actual sale prices ranged from $68.365 to $68.90. Represents weighted average sale price. Actual sale prices ranged from $65.16 to $66.14. Represents weighted average sale price. Actual sale prices ranged from $66.16 to $67.15. Represents weighted average sale price. Actual sale prices ranged from $67.16 to $67.87. /s/ Jason W. Radford, Attorney-in-fact 2018-12-19